Translational Research of the Activation of the C-Type Natriuretic Peptide (CNP)-Guanylyl Cyclase-B Pathway for Skeletal Dysplasia
Authors:
Open Access
- 1 January 2015
- book chapter
- Published by Springer Nature
- p. 177-186
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 GenePLOS ONE, 2012
- Granulosa Cell Ligand NPPC and Its Receptor NPR2 Maintain Meiotic Arrest in Mouse OocytesScience, 2010
- Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal DysplasiasEndocrinology, 2009
- Mutations in the Transmembrane Natriuretic Peptide Receptor NPR-B Impair Skeletal Growth and Cause Acromesomelic Dysplasia, Type MaroteauxThe American Journal of Human Genetics, 2004
- Developmental regulation of the growth plateNature, 2003
- Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptorsJournal Of Hypertension, 1992
- Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".Journal of Clinical Investigation, 1992
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.Journal of Clinical Investigation, 1989